In 2011, a study of 74 PWS patients and 100 healthy controls found that patients with at least one d3 allele had significantly higher height SDS and IGF-1 levels than those with flGHR before starting recombinant human growth hormone (rhGH) therapy [108]. Here, GH1 is linked to Prader-Willi syndrome.